Apr 8, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Identifying and overcoming solubility challenges continues to be an important issue for pharmaceutical and biotech drug manufacturers. Estimates of 70% of new drugs still suffer from solubility issues. As a result, industry has responded with the development of...
Mar 16, 2020 | All Posts, Controlled Release, Main Blog |
The Next Generation of Drug Delivery: Where Are We Headed? The drug delivery technology market continues to grow rapidly from a technology and application standpoint, particularly in the areas of oral, injectable, topical, nasal, ocular, pulmonary, implantable, and...
Sep 13, 2019 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...
Jul 8, 2019 | Main Blog, Peptide |
There are a number of pharmacological and economical benefits to developing controlled and modified release drug products. Following the 505(b)(2) pathway allows companies to make modest changes to an already approved drug and get continued market exclusivity for a...
Oct 3, 2018 | Main Blog |
The drug development model is in need of a drastic shakeup. COVID-19 has only accelerated this. Now more than ever is there a need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic...
Recent Comments